{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:07:02Z","timestamp":1792480022677,"version":"4.5.0"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"7","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2025-0146_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate maternal sociodemographic factors and adverse pregnancy outcomes associated with hepatitis C virus (HCV) infection during pregnancy in a large population of live births.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0146_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective analysis of the United\u00a0States (US) Centers for Disease Control and Prevention Natality Live Birth database (2016\u20132021). All births were eligible for inclusion. Deliveries with missing data on HCV infection were excluded. Multiple sociodemographic factors and adverse pregnancy and neonatal outcomes were compared between pregnancies complicated by maternal HCV infection and those without HCV. Multivariable logistic regression was utilized to evaluate the association of sociodemographic factors with HCV and adjust outcomes for potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0146_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 22,604,938 live births included, 107,761 (0.48\u202f%) were complicated by maternal HCV. Patients with HCV in pregnancy were more likely to be advanced maternal age, have Medicaid insurance, or smokers. In addition, HCV in pregnancy was associated with higher risks of concurrent infections with hepatitis B virus, syphilis, gonorrhea, or chlamydia. HCV was associated with an increased risk of preterm birth\u00a0&lt;37\u00a0weeks, low birthweight, congenital anomalies at birth, low 5-min Apgar scores, NICU admission, antibiotic treatment for suspected neonatal sepsis, as well as immediate and prolonged ventilation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0146_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on this recent, large US population cohort, HCV in pregnancy is more commonly associated with certain sociodemographic factors and several adverse pregnancy and neonatal outcomes. These data are an important step in the attempt to identify at-risk patients and employ strategies to better manage and optimize care for these pregnancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2025-0146","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T03:31:11Z","timestamp":1748316671000},"page":"821-826","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors and adverse outcomes associated with hepatitis C virus in pregnancy"],"prefix":"10.1515","volume":"53","author":[{"given":"Moti","family":"Gulersen","sequence":"first","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology , 6529 Sidney Kimmel Medical College of Thomas Jefferson University , Philadelphia , PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Lenchner","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management , New York University Rory Meyers College of Nursing , New York , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Grunebaum","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology , Lenox Hill Hospital\u00a0\u2013\u00a0Zucker School of Medicine at Hofstra\/Northwell , New York , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Chervenak","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology , Lenox Hill Hospital\u00a0\u2013\u00a0Zucker School of Medicine at Hofstra\/Northwell , New York , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Bornstein","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology , Lenox Hill Hospital\u00a0\u2013\u00a0Zucker School of Medicine at Hofstra\/Northwell , New York , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"2026051215463183744_j_jpm-2025-0146_ref_001","doi-asserted-by":"crossref","unstructured":"Viral hepatitis in pregnancy: ACOG clinical practice guideline No. 6. Obstet Gynecol 2023;142:745\u201359.","DOI":"10.1097\/AOG.0000000000005300"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_002","doi-asserted-by":"crossref","unstructured":"Society for Maternal-Fetal Medicine (SMFM), Dotters-Katz, SK, Kuller, JA, Hughes, BL. Society for maternal-fetal medicine consult series #56: hepatitis C in pregnancy-updated guidelines: replaces consult number 43, november 2017. Am J Obstet Gynecol 2021;225:B8\u201318. https:\/\/doi.org\/10.1016\/j.ajog.2021.06.008.","DOI":"10.1016\/j.ajog.2021.06.008"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_003","doi-asserted-by":"crossref","unstructured":"Dienstag, JL, McHutchinson, JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006;130:231\u201364. https:\/\/doi.org\/10.1053\/j.gastro.2005.11.010.","DOI":"10.1053\/j.gastro.2005.11.010"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_004","doi-asserted-by":"crossref","unstructured":"Schillie, S, Wester, C, Osborne, M, Wesolowski, L, Ryerson, AB. CDC recommendations for hepatitis C screening among adults\u00a0\u2013\u00a0United\u00a0States, 2020. MMWR Recomm Rep (Morb Mortal Wkly Rep) 2020;69:1\u201317. https:\/\/doi.org\/10.15585\/mmwr.rr6902a1.","DOI":"10.15585\/mmwr.rr6902a1"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_005","doi-asserted-by":"crossref","unstructured":"Trickey, A, Fraser, H, Lim, AG, Peacock, A, Colledge, S, Walker, JG, et al.. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol Hepatol 2019;4:435\u201344. https:\/\/doi.org\/10.1016\/s2468-1253(19)30085-8.","DOI":"10.1016\/S2468-1253(19)30085-8"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_006","doi-asserted-by":"crossref","unstructured":"Benova, L, Mohamoud, YA, Calvert, C, Abu-Raddad, LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 2014;59:765\u201373. https:\/\/doi.org\/10.1093\/cid\/ciu447.","DOI":"10.1093\/cid\/ciu447"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_007","doi-asserted-by":"crossref","unstructured":"Connell, LE, Salihu, HM, Salemi, JL, August, EM, Weldeselasse, H, Mbah, AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int 2011;31:1163\u201370. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02556.x.","DOI":"10.1111\/j.1478-3231.2011.02556.x"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_008","doi-asserted-by":"crossref","unstructured":"Huang, QT, Hang, LL, Zhong, M, Gao, YF, Luo, ML, Yu, YH. Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies. Medicine (Baltim) 2016;95:e4777. https:\/\/doi.org\/10.1097\/md.0000000000004777.","DOI":"10.1097\/MD.0000000000004777"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_009","doi-asserted-by":"crossref","unstructured":"Abu Freha, N, Wainstock, T, Poupko, L, Yonat Shemer, A, Sergienko, R, Sheiner, E. Maternal hepatitis B or C virus carrier status and long-term infectious morbidity of the offspring: a population-based cohort study. J\u00a0Viral Hepat 2020;27:794\u20139. https:\/\/doi.org\/10.1111\/jvh.13300.","DOI":"10.1111\/jvh.13300"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_010","doi-asserted-by":"crossref","unstructured":"Yoles, I, Sheiner, E, Abu-Freha, N, Wainstock, T. Maternal hepatitis B or C virus carrier status and long-term neurological morbidity of the offspring: a population-based cohort study. J\u00a0Dev Orig Health Dis 2022;13:115\u201319. https:\/\/doi.org\/10.1017\/s2040174420001397.","DOI":"10.1017\/S2040174420001397"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_011","doi-asserted-by":"crossref","unstructured":"Abu Freha, N, Wainstock, T, Menachem, TN, Sheiner, E. Maternal hepatitis B virus or hepatitis C virus carrier status and long-term endocrine morbidity of the offspring- A population-based cohort study. J\u00a0Clin Med 2020;9:796. https:\/\/doi.org\/10.3390\/jcm9030796.","DOI":"10.3390\/jcm9030796"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_012","doi-asserted-by":"crossref","unstructured":"Rossi, RM, Wolfe, C, Brokamp, R, McAllister, JM, Wezelblatt, S, Warshak, CR, et al.. Reported prevalence of maternal hepatitis C virus infection in the United\u00a0States. Obstet Gynecol 2020;135:387\u201395. https:\/\/doi.org\/10.1097\/aog.0000000000003644.","DOI":"10.1097\/AOG.0000000000003644"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_013","doi-asserted-by":"crossref","unstructured":"US Preventive Services Task Force, Owens, DK, Davidson, KW, Krist, AH, Barry, MJ, Cabana, M, Caughey, AB, et al.. Screening for hepatitis C infection in adolescents and adults: US preventive Services Task Force recommendation statement. JAMA 2020;323:970\u20135. https:\/\/doi.org\/10.1001\/jama.2020.1123.","DOI":"10.1001\/jama.2020.1123"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_014","unstructured":"Centers for Disease Control and Prevention. CDC wonder natality information: natality for 2016-2021 (expanded) 2023. Available at: https:\/\/wonder.cdc.gov\/natality-expanded-current.html [Accessed 16 July 2023]."},{"key":"2026051215463183744_j_jpm-2025-0146_ref_015","unstructured":"Gregory, ECW, Martin, JA, Argov, EL, Osterman, MJK. Assessing the quality of medical and health data from the 2003 birth certificate revision: results from New York City. Natl Vital Stat Rep 2019;68:1\u201320."},{"key":"2026051215463183744_j_jpm-2025-0146_ref_016","unstructured":"Centers for Disease Control and Prevention. CDC wonder data use restrictions 2022. Available at: https:\/\/wonder.cdc.gov\/DataUse.html [Accessed 27 July 2023]."},{"key":"2026051215463183744_j_jpm-2025-0146_ref_017","unstructured":"Shen, GF, Ge, CH, Shen, W, Liu, YH, Huang, XY. Association between hepatitis C infection during pregnancy with maternal and neonatal outcomes: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 2023;27:3475\u201388. https:\/\/doi.org\/10.26355\/eurrev_202304_32120."},{"key":"2026051215463183744_j_jpm-2025-0146_ref_018","doi-asserted-by":"crossref","unstructured":"Arditi, B, Emont, J, Friedman, AM, D\u2019Alton, ME, Wen, T. Deliveries among patients with maternal hepatitis C virus infection in the United\u00a0States, 2000-2019. Obstet Gynecol 2023;141:828\u201336. https:\/\/doi.org\/10.1097\/aog.0000000000005119.","DOI":"10.1097\/AOG.0000000000005119"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_019","doi-asserted-by":"crossref","unstructured":"Hughes, BL, Sandoval, GJ, Saade, GR, Clifton, RG, Reddy, UM, Bartholomew, A, et al.. Pregnancy outcomes in patients with hepatitis C virus infection. Obstet Gynecol 2024;144:501\u20136. https:\/\/doi.org\/10.1097\/aog.0000000000005703.","DOI":"10.1097\/AOG.0000000000005703"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_020","unstructured":"Centers for Disease Control and Prevention. Interpretation of results of tests for hepatitis C virus infection and further actions. Available at: https:\/\/www.cdc.gov\/hepatitis\/hcv\/pdfs\/hcv_graph.pdf [Accessed 4 December 2024]."},{"key":"2026051215463183744_j_jpm-2025-0146_ref_021","doi-asserted-by":"crossref","unstructured":"Fallahi, P, Ferri, C, Ferrari, SM, Corrado, A, Sansonno, D, Antonelli, A. Cytokines and HCV-related disorders. Clin Dev Immunol 2012;2012:468107. https:\/\/doi.org\/10.1155\/2012\/468107.","DOI":"10.1155\/2012\/468107"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_022","doi-asserted-by":"crossref","unstructured":"Wei, SQ, Fraser, W, Luo, ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol 2010;116:393\u2013401. https:\/\/doi.org\/10.1097\/aog.0b013e3181e6dbc0.","DOI":"10.1097\/AOG.0b013e3181e6dbc0"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_023","doi-asserted-by":"crossref","unstructured":"Hurtado, CW, Golden-Mason, L, Brocato, M, Krull, M, Narkewicz, MR, Rosen, HR. Innate immune function in placenta and cord blood of hepatitis C\u2014seropositive mother-infant dyads. PLoS One 2010;5:e12232. https:\/\/doi.org\/10.1371\/journal.pone.0012232.","DOI":"10.1371\/journal.pone.0012232"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_024","doi-asserted-by":"crossref","unstructured":"Chappell, CA, Scarsi, KK, Kirby, BJ, Suri, V, Gaggar, A, Bogen, DL, et al.. Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study. Lancet Microbe 2020;1:e200\u20138. https:\/\/doi.org\/10.1016\/s2666-5247(20)30062-8.","DOI":"10.1016\/S2666-5247(20)30062-8"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_025","doi-asserted-by":"crossref","unstructured":"Mason, AL, Lau, JY, Hoang, N, Qian, K, Alexander, GJ, Xu, L, et al.. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328\u201333. https:\/\/doi.org\/10.1002\/hep.510290235.","DOI":"10.1002\/hep.510290235"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_026","doi-asserted-by":"crossref","unstructured":"Chen, J, Qiu, P, Zhao, T, Jiang, H, Tursun, K, Ksimu, S, et al.. Measures of insulin resistance and beta cell function before and after treatment of HCV infection. Virol Sin 2024;39:667\u201374. https:\/\/doi.org\/10.1016\/j.virs.2024.06.007.","DOI":"10.1016\/j.virs.2024.06.007"},{"key":"2026051215463183744_j_jpm-2025-0146_ref_027","doi-asserted-by":"crossref","unstructured":"Chen, PH, Johnson, L, Limketkai, BN, Jusuf, E, Sun, J, Kim, B, et al.. Trends in the prevalence of hepatitis C infection during pregnancy and maternal-infant outcomes in the US, 1998 to 2018. JAMA Netw Open 2023;6:e2324770. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.24770.","DOI":"10.1001\/jamanetworkopen.2023.24770"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0146\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:47:08Z","timestamp":1778600828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0146\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,5,28]]},"published-print":{"date-parts":[[2025,9,25]]}},"alternative-id":["10.1515\/jpm-2025-0146"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2025-0146","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}